Perioperative intravenous lidocaine in thoracoscopic surgery for improved postoperative pain control: a randomized, placebo-controlled, double-blind, superiority trial
Journal of Thoracic Disease · 2024-03 · 16 (3) · 1923-1932
DOI: 10.21037/jtd-23-1438 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Thoracic Disease, 2024-03. Verfasst von Aljaz Hojski und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, University Hospital Basel, Basel, Switzerland. Die Arbeit wurde bisher 11-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Themen: Schmerzmanagement
Abstract (Originalsprache)
Background
Pain, including associated pain management, remains a burden on patients after thoracic surgery. Our objective was to investigate whether perioperative intravenous administration of lidocaine reduces postoperative morphine consumption and pain intensity after video-assisted thoracoscopic surgery (VATS).
Methods
In this double-blind, placebo-controlled superiority trial, patients undergoing VATS with a planned duration of ≤90 minutes were randomized within an intention-to-treat setting. Patients received either intravenous lidocaine or placebo as a bolus of 1.5 mg/kg 30 minutes before incision, followed by a continuous infusion of 3.0 mg/kg/hour until 2 hours after skin closure. Pain and morphine consumption were evaluated when resting and when coughing 1, 2, 4, 8, 16, 24, and 48 hours after skin closure and in a follow-up 14, 90, and 180 days postoperatively.
Results
Twenty-eight patients were included in the lidocaine group, 24 in the placebo group. Patients' characteristics and preoperative pain scores were similar in both groups. When coughing, patients of the lidocaine group had less pain within 24 hours after skin closure than the placebo group (4.60±1.64 vs. 5.52±1.65; P=0.02). Morphine consumption was not statistically significantly lower in lidocaine group (18.22±12.87 vs. 21.26±9.39 mg; P=0.26). There were no significant differences between groups in secondary outcomes.
Conclusions
Our results suggest that perioperative intravenous lidocaine administration reduces pain scores after VATS. The beneficial clinical effects are limited. Nevertheless, intravenous lidocaine may be helpful as part of a multimodal analgesia protocol or with patients in whom the use of other analgesics is contraindicated. Trial Registration: ClinicalTrials.gov NCT03677817.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Thoracic Surgery, University Hospital Basel, Basel, Switzerland.
- Department of Anesthesiology, University Hospital Basel, Basel, Switzerland.
- Department of Clinical Research, University of Basel, Basel, Switzerland.
Zitieren
APA
Hojski, A., Bolliger, D., Mallaev, M., Dackam, S., Tsvetkov, N., Wiese, M., Schneider, T., Lampart, A., & Lardinois, D. (2024). Perioperative intravenous lidocaine in thoracoscopic surgery for improved postoperative pain control: a randomized, placebo-controlled, double-blind, superiority trial. Journal of Thoracic Disease, 16(3), 1923-1932. https://doi.org/10.21037/jtd-23-1438
Vancouver
Hojski A, Bolliger D, Mallaev M, Dackam S, Tsvetkov N, Wiese M, et al. Perioperative intravenous lidocaine in thoracoscopic surgery for improved postoperative pain control: a randomized, placebo-controlled, double-blind, superiority trial. Journal of Thoracic Disease. 2024;16(3):1923-1932. doi:10.21037/jtd-23-1438
BibTeX
@article{Hojski2024,
author = {Hojski, Aljaz and Bolliger, Daniel and Mallaev, Makhmudbek and Dackam, Sandrine and Tsvetkov, Nikolay and Wiese, Mark and Schneider, Tobias and Lampart, Andreas and Lardinois, Didier},
title = {Perioperative intravenous lidocaine in thoracoscopic surgery for improved postoperative pain control: a randomized, placebo-controlled, double-blind, superiority trial},
journal = {Journal of Thoracic Disease},
year = {2024},
volume = {16},
number = {3},
pages = {1923--1932},
doi = {10.21037/jtd-23-1438}
}
EUVIMED